CRISPR Therapeutics to Present New Data on Allogeneic CRISPR-based CAR-T Program and Host Investor … – Markets Insider
CRISPR Therapeutics to Present New Data on Allogeneic CRISPR-based CAR-T Program and Host Investor …Markets InsiderZUG, Switzerland and CAMBRIDGE, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a genome editing company fo… Continue reading
